- Rating
- 2
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 1
Read review
Paper summary
This paper proposes MealGluco for predicting a 2-hour post-meal continuous glucose monitoring (CGM) trajectory from 2 hours of pre-meal CGM, and meal nutrients. The population prediction adds the mealtime glucose anchor to a bounded state-response pathway (combining a frozen CGM-JEPA encoder, four short-horizon summary statistics, and time queries) and a meal-response pathway parameterized as a three-variable unimodal Gamma curve. After each completed meal, participant-specific coordinates scaling meal amplitude and post-peak clearance are updated online.
Critical strengths
Well-motivated formulation and comprehensive evaluation: Predicting complete postprandial trajectories across five complementary shape and timing metrics under participant-disjoint splits is a practical formulation, and the authors include participant-clustered paired bootstrap confidence intervals (Appendix C.6), a comparison against per-participant fine-tuning, and a wrong-subject history control (Table 15).
Lightweight online personalization mechanism by updating only two scalar response coordinates.
Critical weaknesses
- Unmatched online adaptation in baseline comparisons and overstated universal ablation claims:
-
Architectural gains are confounded with online adaptation: In both the main tables and cross-dataset transfer (Table 3), MealGluco updates its participant-specific coordinates online using completed target-participant meals, whereas all competing baselines are evaluated with fixed population weights.
-
In Table 20, the 95% confidence intervals show that MealGluco does not significantly beat the strongest baseline on any of the five metrics on BIG IDEAs (and is significantly worse on Recovery-MAE by +1.43 mg/dL) and only significantly improves two of five metrics on T1D-UOM. Moreover, contrary to the claim in Section 4 that removing any proposed module degrades performance across all datasets, Table 28 shows that 0 of 10 component ablations on T1D-UOM and only 3 of 10 on BIG IDEAs have confidence intervals excluding zero for Trajectory-MAE.
-
Structural priors vs. physiological identification: Training supervises only the sum of the state and meal branches, and T1D-UOM lacks insulin records (Appendix B.1), meaning the conditional forecast cannot disentangle nutritional responses from unobserved prandial insulin dosing. Similarly, the nutrient sensitivities in Figure 5(c) partly reflect imposed structural priors (explicit amplitude-attenuation and peak-delay modifiers, plus a hardcoded gate forcing the meal response to zero whenever carbohydrate is zero, Appendix A.4.2) rather than independent physiological validation. Furthermore, because the meal kernel is nonnegative and the state residual is bounded, the population model is mathematically incapable of predicting glucose drops more than 20 mg/dL below the mealtime anchor (or 40 mg/dL after personalization).
-
Furthermore, the evaluation deletes all meals with incomplete macronutrients upstream (Appendix B.1) and includes no robustness analysis for noisy or partially missing self-reported food logs. This is a critical gap for free-living deployment, where mislogging errors will also propagate into the recursive personalization state.
Questions for authors
-
Can you reconcile the CGMacros reference numbers between Table 5 (22.68 / 28.16) and Table 12 (22.63 / 26.96), explain why the ablation deltas in Table 28 differ from Table 12, and confirm whether the 20 mg/dL state bound in Appendix B.4.2 was selected strictly on inner validation or on outer-fold test scores?
-
How do the strongest baselines (Stacking Framework and UniCA-Gluformer) perform in within-dataset and cross-dataset evaluations when equipped with a comparable lightweight online calibration fitted on the exact same completed meal histories?
-
Given that an unstructured meal head outperforms the Gamma kernel on Peak-MAE and Recovery-MAE in several datasets and removing the state pathway improves peak timing and recovery on CGMacros, how do you justify the claim that every proposed component provides a consistent benefit across metrics and cohorts?
-
How frequently do real post-meal trajectories in your three datasets drop more than 20 mg/dL (population) or 40 mg/dL (personalized) below the mealtime anchor and how should the meal branch on T1D-UOM be interpreted given the absence of prandial insulin records?
3 comments
Q3: Given that an unstructured meal head outperforms the Gamma kernel on Peak-MAE and Recovery-MAE in several datasets and removing the state pathway improves peak timing and recovery on CGMacros, how do you justify the claim that every proposed component provides a consistent benefit across metrics and cohorts?
A3: We agree that some statements in the original manuscript could lead readers to understand that all modules consistently improve every metric across all three datasets. We have revised the main text to read: “The component ablation results confirm that each proposed module contributes to the model’s overall forecasting performance. Specifically, removing any module consistently increases Trajectory-MAE across all three datasets.”, and deleted “Across all three datasets, removing any proposed module leads to a clear performance drop.”, which was too absolute (page 9).
Q4.1: How frequently do real post-meal trajectories in the three datasets drop more than mg/dL below the mealtime anchor for the population model, or more than 40 mg/dL below it for the personalized model?
A4.1: We counted the proportion of meals in which the real post-meal trajectory falls at least 20 or 40 mg/dL below the mealtime anchor at any point. Larger post-meal declines are more common in T1D-UOM, consistent with the general pattern of insulin action and larger post-meal declines in people with type 1 diabetes.
| Dataset | Meals | Drop mg/dL | Drop mg/dL |
|---|---|---|---|
| CGMacros | 1,650 | 278 (16.8%) | 94 (5.7%) |
| BIG IDEAs | 534 | 91 (17.0%) | 30 (5.6%) |
| T1D-UOM | 1,487 | 597 (40.1%) | 338 (22.7%) |
We further conducted an sensitivity analysis on T1D-UOM. The experiment followed exactly the same configuration and protocol as the main results, changing only from 20 mg/dL to 40 mg/dL before retraining and evaluation. The results have been added to Table 8 (page 28) and are also shown below for your convenience. A negative Relative change indicates lower error for . The results show that increasing does not lead to consistent improvement across metrics. Therefore, a larger is not an effective way to improve overall predictive performance.
| Trajectory-MAE | iAUC-MAE | Peak-MAE | Near-Peak Distance | Recovery-MAE | |
|---|---|---|---|---|---|
| 20 | 30.08 ± 0.55 | 1986.8 ± 45.3 | 31.87 ± 0.53 | 24.83 ± 1.54 | 24.06 ± 0.55 |
| 40 | 29.94 ± 0.49 | 1968.0 ± 49.2 | 31.71 ± 0.59 | 26.63 ± 1.03 | 24.58 ± 0.38 |
| Relative change | −0.46% | −0.95% | −0.50% | +7.26% | +2.17% |
Q4.2: How should the meal branch on T1D-UOM be interpreted given the absence of prandial insulin records?
A4.2: We would like to clarify that the absence of prandial insulin records does not mean that the meal branch is invalid. People without diabetes also secrete insulin after meals, and this process is not an observed input either. Postprandial glucose prediction can still be performed based on pre-meal CGM, meal nutrient composition, and individual history. Therefore, our meal branch models the nutrient-conditioned component of the observed postprandial response.
Under our protocol, MealGluco and all baselines use the same inputs without insulin. None explicitly models the effect of injected insulin on postprandial glucose, and our experiments show that MealGluco models the effect of diet on postprandial glucose better than the baselines. The larger post-meal declines in T1D-UOM may partly reflect unobserved exogenous insulin and other physiological factors. Although these factors are not provided as explicit input variables, their participant-specific effects are reflected in the historical CGM trajectory and personalization parameters. Adding insulin may improve prediction accuracy for some cases, but it would change the research question and input protocol. This paper focuses on modeling postprandial glucose trajectories based on meal composition and does not model the effects of exogenous insulin. Therefore, the meal branch on T1D-UOM should be interpreted as a conditional prediction component based on meal inputs and individual history, not as an estimate of insulin effects. At the same time, this work focuses on the effects of diet on postprandial glucose.
Note on updated table and page numbers
We have completed a second round of revisions to the manuscript. All newly added and revised content is marked in blue. Because an additional Appendix table has been included, the table numbers and page numbers have changed in the latest PDF. We have updated the relevant table and page references in our response comments above. Please use the numbering in the latest manuscript when checking the revisions. We hope that the revised manuscript now addresses your concerns.
Response to Reviewer q4wT
Thank you for carefully reviewing our work and for your constructive feedback. We have made corresponding revisions to the paper based on your feedback, and all revisions are highlighted in red in the updated PDF. We respond to your questions point by point below.
Q1.1: Can you reconcile the CGMacros reference numbers between Table 5 (22.68 / 28.16) and Table 12 (22.63 / 26.96), and explain why the ablation deltas reported in Table 28 differ from those implied by Table 12?
A1.1: We apologize for this. During the aggregation of the CGMacros data, we mistakenly included results from different experimental batches in the confidence-interval tables, which led to the discrepancy. All CGMacros results have now been updated using the latest data. The table numbering changed in the revised version, and the complete results are now reported in Table 23 and Tables 39–43 (pages 34 and 40).
Q1.2: Was the 20 mg/dL state bound in Appendix B.4.2 selected strictly on inner-validation results, or did outer-fold test scores contribute to its selection?
A1.2: To clarify, the value Rmax=20 mg/dL on CGMacros was selected solely based on the inner-validation Trajectory-MAE results; the outer-fold results were not used in the selection. We clarified this issue in Appendix B.4.2 and added the inner-validation Trajectory-MAE results to Table 6 (page 28). For your convenience, we show the inner-validation Trajectory-MAE results below. The inner-validation Trajectory-MAE varies by only 0.345 mg/dL across the six candidates, indicating that model performance is not sensitive to Rmax.
Q2: How do the strongest baselines (Stacking Framework and UniCA-Gluformer) perform in within-dataset and cross-dataset evaluations when equipped with a comparable lightweight online calibration fitted on the exact same completed meal histories?
A2: As requested, we used the same lightweight online calibration as MealGluco for Stacking Framework and UniCA-Gluformer, and recalculated the within-dataset and cross-dataset metrics using the same historical meal information. For your convenience, we show the relevant results below. The complete results for all five metrics are reported in Table 1, Table 3, Appendix C.1, and Appendix C.5 (pages 7, 9, 29, and 35).
Within-dataset
Cross-dataset